Late Envelope Protein 18 (LCE18) and Its Potential Drug Target Status

Target Name: LCE5A

NCBI ID: G254910

LCE5A

Late Envelope Protein 18 (LCE18) and Its Potential Drug Target Status

Late Envelope Protein 18 (LCE18) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the lateenvelope family of proteins, which are involved in the regulation of cell signaling pathways . LCE18 has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion.

One of the unique features of LCE18 is its ability to interact with the protein F-actinin. F-actinin is a protein that is involved in cell adhesion and migration, and it has been shown to play a role in the regulation of LCE18 function. LCE18 and F-actinin have been shown to form a complex that is involved in the regulation of cell adhesion and migration.

Another protein that has been shown to interact with LCE18 is the protein tyrosine kinase (TK). TK is a protein that is involved in the regulation of cell signaling pathways, and it has been shown to play a role in the regulation of LCE18 function. LCE18 and TK have been shown to form a complex that is involved in the regulation of cell signaling pathways.

In addition to its role in cell signaling pathways, LCE18 has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues. For example, LCE18 has been shown to play a role in the regulation of cell division, and it has been shown to be involved in the regulation of cell proliferation.

LCE18 has also been shown to play a role in the regulation of cellular processes that are important for the maintenance of tissues. For example, LCE18 has been shown to play a role in the regulation of cell death, and it has been shown to be involved in the regulation of cell apoptosis.

Given its role in several cellular processes, LCE18 is a potential drug target or biomarker. Researchers are currently working to develop new treatments for diseases that are caused by the regulation of LCE18 function. For example, researchers are studying the effects of inhibiting LCE18 function on the regulation of cell signaling pathways, in order to develop new treatments for diseases that are caused by the regulation of these pathways.

In conclusion, LCE18 is a protein that is involved in several cellular processes that are important for the development and maintenance of tissues. It is a potential drug target or biomarker, and researchers are currently working to develop new treatments for diseases that are caused by the regulation of LCE18 function.

Protein Name: Late Cornified Envelope 5A

Functions: Precursors of the cornified envelope of the stratum corneum

The "LCE5A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LCE5A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets